let me try to explain. Yu
Anp re Atl1102 is for Non Ambulant boys with DMD( but could also work in Ambulant boys( Sarepta is only treating ambulant boys … but FDA want Sarepta to show data Re efficacy )
Now Atl1102 shows potential to treat Limb girdle (R2)
Sarepta does not have the Science (R2)
So this is another market Anp could capture.
Long Covid potential in discussion with interested parties;
So each indication : Neuro muscular or Neuro Skeletal are yet to be defined.. in other words there are a many Rare Diseases that could be treated ( inflammation and fibrosis )
Hope that helps
We Wait $$
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-1957
-
- There are more pages in this discussion • 1,570 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.32M |
Open | High | Low | Value | Volume |
7.8¢ | 7.9¢ | 7.8¢ | $16.54K | 212.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6454 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 12975 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6454 | 0.077 |
1 | 75000 | 0.076 |
5 | 206544 | 0.075 |
4 | 420708 | 0.074 |
1 | 100000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 12975 | 1 |
0.080 | 203231 | 1 |
0.081 | 150000 | 2 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online